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Identity 
Other names: HsTRAD; R51H3; RAD51D; Trad 
HGNC (Hugo): RAD51D 
Location: 17q12 
Note 
Of the five RAD51 paralog proteins, four come 
together to form the BCDX2 complex, which includes 
RAD51L1 (RAD51B; chromosome 14), RAD51L2 
(RAD51C; chromosome 17), RAD51L3 (RAD51D; 
chromosome 17), and XRCC2 (chromosome 14). The 
protein complex is involved in homologous 
recombination repair of double-stranded breaks that 
result during DNA replication or from DNA-damaging 
agents, e.g., cisplatin (Masson et al., 2001). 
The RAD51L3 protein directly interacts with 
RAD51L2 (RAD51C) and XRCC2. It does not directly 




The human gene is composed of 10 exons. The study 
by Kawabata and Saeki (1999) describes alternative 
splicing of the human gene using a numbering scheme 
of 12 alternatively spliced exons. The exon alignmet 
is illustrated below. 
 
Human RAD51D alternative splicing. A. Exons 4 and 8 of the Kawabata and Saeki numbering scheme are considered "alternative 
exons" and not included in the reference sequence. B. Summary of splice variants and predicted translation products (for further details 
see the annexed document below). 
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Further descriptions of mouse alternatively spliced 
variants are described in Gruver et al., 2009 and 
Kawabata et al., 2004. 
Transcription 
The HsTRAD transcript is the predominant variant. It 
is the full-length transcript and is made up of 2418 base 
pairs. This transcript will be used as the reference for 
the information that follows. There are multiple splice 
variants for the RAD51L3 gene that translate into one 
of seven putative protein isoforms. 
Protein 
Note 
The Saccharomyces cerevisiae Rad51 protein is 
homologous to the RecA protein of Escherichia coli. 
The RecA protein is known to promote repair via ATP-
dependent mechanisms and is responsible for pairing 
and strand transfer between homologous DNA 
sequences. This is similar to the actions of the RAD51 
protein in repair pathways. There are 5 members of the 
RAD51 family that share similar roles in recombinaton 
and DNA repair. RAD51D is one of these RecA-like 
genes (Pittman et al., 1998; Cartwright et al., 1998). 
The RAD51D gene is predicted to encode seven 
different protein isoforms through alternative splicing. 
Isoform 1 is the predominant protein and is translated 
from the HsTRAD transcript mentioned previously 
(Kawabata and Saeki, 1999). The diagram below is 
based on this predominant form. 
Description 
The RAD51D protein contains regions necessary for 
interactions with other RAD51 paralogs as well as 
those that are required for proper function of the 
protein. RAD51D contains an ATP binding domain 
with highly conserved Walker A and B motifs (Pittman 
et al., 1998; Cartwright et al., 1998). Mutations 
targeting the conserved residues of glycine and lysine 
within the Walker A motif region resulted in a 
reduction in RAD51C binding ability and were shown 
to be required for DNA repair (Gruver et al., 2005). 
The Walker B motif contains a "GGQRE" sequence 
between residues 219-223 that is also required for DNA 
repair (Wiese et al., 2006). Furthermore, RAD51D-
XRCC2 complex formation is significantly reduced 
with mutations targeting a highly conserved aspartate 
residue within the Walker B motif (Wiese et al., 2006). 
A carboxyl terminal domain spanning amino acids 77-
329 has been identified to be required for RAD51D to 
interact with RAD51C.  
In addition, the "linker region" located between  
residues 54-77 in the amino terminus is required for 
proper interactions with XRCC2. Together, these 
interactions aid in the repair of DNA damage (Miller et 
al., 2004; Gruver et al., 2009). 
Expression 
According to the study by Kawabata and Saeki (1999), 
RAD51L3 transcripts are expressed to varying degrees 
in the colon, prostate, spleen, testis, ovaries, thymus, 
small intestine and leukocytes. 
Localisation 
Located in the nucleus. Specifically, RAD51L3 
localizes to the telomeres during both mitosis and 
meiosis (Tarsounas et al., 2004). There is evidence that 
RAD51L3 is found in the cytoplasm as well (Gruver et 
al., 2005). 
Function 
RAD51D is one of five members of the RAD51 gene 
family that is known to participate in repair of double 
stranded DNA breaks via homologous recombination. 
Without repair, the DNA damage can result in cell 
death or chromosomal aberrations that can ultimately 
lead to cancer (Thacker, 2005). Knockout studies with 
mice have shown a dramatic increase in levels of 
chromosomal aberrations, most notably, chromatid and 
chromosome breaks that occur through unrepaired 
replication forks (Smiraldo et al., 2005; Hinz et al., 
2006). Proteomic studies have identified an interaction 
between RAD51D with the SFPQ protein (Rajesh et al., 
2011). Exposure of mouse RAD51D-deficient cells to a 
strong alkylating agent results in G2/M cell cycle arrest 
and ultimately apoptosis (Rajesh et al., 2010). 
RAD51D has recently been shown to play a diverse 
role in cellular processes through its interaction with 
proteins involved in cell division, embryo development, 
protein and carbohydrate metabolism, cellular 
trafficking, protein synthesis, modification or folding, 
and cellular structure (Rajesh et al., 2009). 
RAD51L3 is directly associated with telomeres 
prevents their dysfunction (Tarsounas et al., 2004). In 
mouse studies, RAD51L3 foci were present at 
telomeres in both meiosis and mitosis. Knockout 
studies showed that "RAD51D-deficient" mice 
exhibited an increase in end-to-end fusion and telom re 
attrition (Smiraldo et al., 2005). In addition, human 
studies using RAD51D-deficient cells have shown 
repeated shortening of the telomeric DNA, leading to 
chromosomal instability. This suggests a role for 
"RAD51D" in telomere capping. Failure to provide this 
function can lead to chromosomal aberrations 
(Tarsounas and West, 2005). 
 
RAD51L3 protein structure. Isoform 1 (from full-length transcript). 






Atlas Genet Cytogenet Oncol Haematol. 2011; 15(8)  634 
Homology 
Canis lupus familiaris 
[Dog] 
Official gene name:  
RAD51-like 3 (S. cerevisiae) 
Genomic location:  
chromosome 9 
Reference material:  
no primary references found 
Pan troglodytes 
[Chimpanzee] 
Official gene name:  
RAD51-like 3 (S. cerevisiae) 
Genomic location: 
chromosome 17 
Reference material:  
no primary references found 
Bos taurus 
[Cow] 
Official gene name:  
RAD51-like 3 (S. cerevisiae) 
Genomic location:  
chromosome 19 
Reference material:  
Zimin et al., 2009 
Gallus gallus 
[Chicken] 
Official gene name:  
RAD51-like 3 (S. cerevisiae) 
Genomic location: 
chromosome 19 
Reference material:  
no primary references found 
Rattus norvegicus 
[Rat] 
Official gene name:  
RAD51-like 3 (S. cerevisiae) 
Genomic location:  
chromosome 10 
Reference material:  
Strausberg et al., 2002 
Mus musculus 
[Mouse] 
Official gene name:  




Pittman et al., 1998 
Cartwright et al., 1998 
Arabidopsis thaliana 
[Thale cress] 
Official gene name:  




Reference material:  
Durrant et al., 2007 
Oryza sativa 
[Rice] 
Official gene name:  
Os09g0104200 
Genomic location:  
chromosome 9 
**Hypothetical protein** 
Reference material:  
no primary references found 
Danio rerio 
[Zebrafish] 
Official gene name:  
zgc:77165 
Genomic location:  
chromosome 5 
Reference material:  
no primary references found 
 




Single nucleotide polymorphisms have been identified 
in RAD51L3. However, only a small number of the 
major mutations occur in coding regions. The majority 
of the other mutations are present in various locati ns 
within the introns. Of the mutations affecting the g ne, 
only one has an observed clinical association. It is 
observed that a mutation of the mRNA position 954  
(SNP ID: rs28363284) results in an allele change to 
GGG (from the wild type GAG). This point mutation 
affects the 233rd amino acid as a glycine residue is 
observed in this particular mutation rather than the
natural glutamic acid. This particular variation in amino 
acid sequence has been implicated as a precursor to 
breast cancer (see "Implicated In" section below). 
Another mutation observed in the coding region is at 
mRNA position 188 (SNP ID: rs1871892), resulting in 
a change in the sequence to TCA (from the wild type  
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CCA). This particular substitution results in the 
insertion of proline at the 36th protein position rather 
than a serine.  
A third mutation observed is noted to occur at mRNA 
positions 810 (SNP ID: rs4796033). A mutation at this 
location results in a sequence of CAG (from the natural 
CGG). The effect of this substitution is the insertion of 
a glutamine residue at the 185th amino acid position 
rather than the arginine observed in the wild type gene. 
It is noted, that this particular mutation also occurs in 2 
additional transcripts of the gene at the mRNA 
positions 750 and 414 affecting the 165th and 53rd 
amino acid residues respectively. Other mutations in 
the coding region include E237K (SNP ID: 
rs115031549), R252Q (SNP ID: rs28363283), A245T 
(SNP ID: rs28363282), A210T (SNP ID: rs80116829), 





Cancer arises in part due to the accumulation of genetic 
damage. Furthermore, such damage has a greater 
tendency to be found in significant levels when genetic 
repair pathways such as DNA mismatch repair and 
homologous recombination (HR) are defective. 
Involved in the pathway of HR are numerous proteins 
that are known as the RAD51 paralogs (RAD51L1, 
RAD51L2, RAD51L3, XRCC2 and XRCC3). It is 
believed that the lack of genetic stability created from 
the loss of this pathway, HR, is significant in initiation 
and potentially the progression of cancer. In particular, 
defects in the HR pathway have been noted to be 
associated with breast and ovarian cancer (Thacker, 
2005); however, it is plausible that such a defect could 
potentially lead to multiple forms of cancer due to the 
accumulation of genetic mutations (although it takes 
significant damage accumulation to lead to tumor 
formation). A RAD51L3 variant does have an 
association with increased familial breast cancer risk
(Rodríguez-López et al., 2004). 
Breast cancer 
Note 
Although conflicting data exist, the RAD51D-E233G 
variant allele has been identified as a potential 
precursor to breast cancers in women with high famili l 
risk but do not possess a BRCA1/BRCA2 mutation 
(Rodríguez-López et al., 2004; Dowty et al., 2008). 
Disease 
In an initial study that screened for possible breast 
cancer alleles, it was determined that the exon 8 
mutation led to an increased frequency of breast cancer 
in a specific group of cases (familial cancer cases) 
versus the control group (Rodríguez-López et al., 
2004). Additionally, individuals expressing the  
RAD51D-E233G variant have been shown to have 
higher proliferative indices and a less favorable clinical 
immunohistochemical pattern (Rodríguez-López et al., 
2004). However, another study found no statistically 
significant evidence that this variant is associated with 
breast cancer risk. Yet, this study did find that it was 
plausible that the variable could lead to a small increase 
in the risk of breast cancer and that a small, yet 
insignificant, effect was made by the variant on the risk 
of breast cancer (approximately 30%) (Dowty et al.,
2008). 
Prognosis 
It has been noted that the RAD51D-E223G variant 
confers increased resistance to DNA damaging agents 
such as: mitomycin C, cisplatin, ultraviolet light, and 
methyl methane sulfonate, and taxol. This presents 
clinical implications as these are commonly utilized 
therapies. Furthermore, the variant has increased 
cellular proliferation and telomere maintenance 
compared to the wild-type and exhibits reduced 
interaction with the binding partner RAD51C but does 
not affect binding to XRCC2 (Nadkarni et al., 2009b). 
Bloom's syndrome 
Disease 
Bloom's syndrome is an autosomal recessive disorder 
of rare occurrence. Characteristics include short stature, 
immunodeficiency, fertility defects, and increased risk 
for the development of various types of cancer. Cells 
associated with this disorder are noted for their 
genomic instability. They exhibit an increase in sister 
chromatid and homologous chromosome exchanges. In 
normal, healthy cells, BLM, a helicase of the RecQ 
family, interacts with the RAD51L3 portion of the 
RAD51L3-XRCC2 heteromeric complex. Upon joining 
with the complex, BLM disrupts synthetic 4-way 
junctions that resemble Holliday junctions suggesting 
an important role for the protein-protein interaction in 
DNA repair. The mutated form of the gene encoding 
for this protein, which occurs in Bloom's syndrome, 
results in the inability for BLM to bind to RAD51L3. 
Absence of normal BLM function leads to the 
characteristic elevation in recombination events seen in 
Bloom's syndrome (Braybrooke et al., 2003). 
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